6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience while we make the transition.
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
Beate Kampmann, Shabir A. Madhi, Iona Munjal, Eric A.F. Simões, Barbara A. Pahud, Conrado Llapur, Jeffrey Baker, Gonzalo Pérez Marc, David Radley, Emma Shittu, …
The New England journal of medicine, Vol.388(16), pp.1451-1464
Childhood Diseases Global Health Gynecology Gynecology General Infectious Disease Infectious Disease General Neonatology Obstetrics Pediatrics Pediatrics General Vaccines Viral Infections
Maternal vaccination was 82% effective in preventing medically attended RSV-associated lower respiratory tract illness in infants within 90 days after birth and 69% effective within 180 days.